GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogened SA (WAR:BGD) » Definitions » E10

Biogened (WAR:BGD) E10 : zł1.32 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Biogened E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biogened's adjusted earnings per share data for the three months ended in Mar. 2025 was zł0.942. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł1.32 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Biogened's average E10 Growth Rate was 12.80% per year. During the past 3 years, the average E10 Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Biogened was 8.80% per year. The lowest was 8.80% per year. And the median was 8.80% per year.

As of today (2025-07-01), Biogened's current stock price is zł24.20. Biogened's E10 for the quarter that ended in Mar. 2025 was zł1.32. Biogened's Shiller PE Ratio of today is 18.33.

During the past 13 years, the highest Shiller PE Ratio of Biogened was 27.50. The lowest was 7.24. And the median was 13.64.


Biogened E10 Historical Data

The historical data trend for Biogened's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogened E10 Chart

Biogened Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.97 1.01 1.12 1.25

Biogened Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.17 1.22 1.27 1.25 1.32

Competitive Comparison of Biogened's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Biogened's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogened's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biogened's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biogened's Shiller PE Ratio falls into.


;
;

Biogened E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biogened's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.942/157.0208*157.0208
=0.942

Current CPI (Mar. 2025) = 157.0208.

Biogened Quarterly Data

per share eps CPI Adj_EPS
201506 0.229 100.448 0.358
201509 0.415 99.634 0.654
201512 0.497 99.471 0.785
201603 0.214 98.983 0.339
201606 0.129 99.552 0.203
201609 0.144 99.064 0.228
201612 -0.032 100.366 -0.050
201703 0.195 101.018 0.303
201706 0.165 101.180 0.256
201709 0.060 101.343 0.093
201712 -0.012 102.564 -0.018
201803 0.201 102.564 0.308
201806 0.176 103.378 0.267
201809 0.040 103.378 0.061
201812 0.046 103.785 0.070
201903 0.255 104.274 0.384
201906 0.152 105.983 0.225
201909 0.027 105.983 0.040
201912 0.084 107.123 0.123
202003 0.321 109.076 0.462
202006 0.096 109.402 0.138
202009 0.129 109.320 0.185
202012 -0.041 109.565 -0.059
202103 0.375 112.658 0.523
202106 0.299 113.960 0.412
202109 0.024 115.588 0.033
202112 0.100 119.088 0.132
202203 0.704 125.031 0.884
202206 0.659 131.705 0.786
202209 0.125 135.531 0.145
202212 -0.112 139.113 -0.126
202303 0.765 145.950 0.823
202306 0.648 147.009 0.692
202309 0.241 146.113 0.259
202312 0.421 147.741 0.447
202403 0.856 149.044 0.902
202406 0.664 150.997 0.690
202409 0.043 153.439 0.044
202412 0.298 154.660 0.303
202503 0.942 157.021 0.942

Add all the adjusted EPS together and divide 10 will get our e10.


Biogened  (WAR:BGD) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biogened's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=24.20/1.32
=18.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Biogened was 27.50. The lowest was 7.24. And the median was 13.64.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Biogened E10 Related Terms

Thank you for viewing the detailed overview of Biogened's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogened Business Description

Traded in Other Exchanges
N/A
Address
Ulica Pojezierska 99, Lodz, POL, 91-342
Biogened SA is a Polish cosmetic company. The company defined its key areas of activity, concentrated its efforts on the development of neurological and psychiatric products. It also develops, produces and distributes ingredients, safe and effective dermo cosmetics under the Dermedic brand.

Biogened Headlines

No Headlines